Immunogen (IMGN)

10.47 +0.09 (0.87%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/27/18 *Est.)

Latest Headlines

Form CT ORDER IMMUNOGEN INC May 23, 2018 11:11 AM - SEC Filing Form 8-K IMMUNOGEN INC For: May 16 May 17, 2018 7:51 AM - SEC Filing ImmunoGen (IMGN) option implied volatility, says to present data from FORWARD II trial at ASCO May 17, 2018 6:35 AM - StreetInsider Immunogen (IMGN) Reports Positive Findings from the FORWARD II Study of Mirvetuximab Soravtansine Combination Regimens with Avastin & Carboplatin in Ovarian Cancer May 16, 2018 5:07 PM - StreetInsider ImmunoGen Announces Positive Findings from the FORWARD II Study of Mirvetuximab Soravtansine Combination Regimens with Avastin® and Carboplatin in Ovarian Cancer May 16, 2018 5:01 PM - BizWire Form 10-Q IMMUNOGEN INC For: Mar 31 May 9, 2018 4:35 PM - SEC Filing Form 8-K IMMUNOGEN INC For: May 04 May 4, 2018 6:36 AM - SEC Filing Immunogen (IMGN) Misses Q1 EPS by 6c, Beats on Revenues May 4, 2018 6:35 AM - StreetInsider ImmunoGen Reports Recent Progress and First Quarter 2018 Operating Results May 4, 2018 6:30 AM - BizWire ImmunoGen Announces Webcast of Presentation at Deutsche Bank’s 43rd Annual Health Care Conference May 2, 2018 4:30 PM - BizWire Form DEFA14A IMMUNOGEN INC April 30, 2018 10:36 AM - SEC Filing Form DEF 14A IMMUNOGEN INC For: Jun 20 April 30, 2018 10:31 AM - SEC Filing Form 8-K IMMUNOGEN INC For: Apr 26 April 26, 2018 5:55 PM - SEC Filing Immunogen (IMGN) Reports Successful Completion of Interim Analysis for FORWARD I Phase 3 Trial of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer April 26, 2018 4:38 PM - StreetInsider ImmunoGen Announces Successful Completion of Interim Analysis for FORWARD I Phase 3 Trial of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer April 26, 2018 4:01 PM - BizWire Form 3 IMMUNOGEN INC For: Apr 23 Filed by: McKee Blaine H. April 26, 2018 8:53 AM - SEC Filing Immunogen (IMGN) Names Blaine McKee as EVP & Chief Business Officer April 25, 2018 8:07 AM - StreetInsider ImmunoGen Appoints Blaine McKee as Executive Vice President and Chief Business Officer April 25, 2018 8:00 AM - BizWire ImmunoGen Announces Conference Call to Discuss Its First Quarter 2018 Operating Results April 20, 2018 8:00 AM - BizWire Form 8-K IMMUNOGEN INC For: Apr 06 April 9, 2018 4:44 PM - SEC Filing Form 4 IMMUNOGEN INC For: Mar 31 Filed by: Goldberg Mark Alan April 2, 2018 10:55 AM - SEC Filing Form 4 IMMUNOGEN INC For: Mar 31 Filed by: MITCHELL DEAN J April 2, 2018 10:54 AM - SEC Filing Form 8-K IMMUNOGEN INC For: Mar 27 March 30, 2018 10:47 AM - SEC Filing Pre-Open Movers 03/26: (DRIO) (FINL) (USG) Higher; (PTGX) (BHVN) (NBEV) Lower (more...) March 26, 2018 9:13 AM - StreetInsider Immunogen Inc. (IMGN) PT Lowered to $15 at Leerink Partners March 26, 2018 6:13 AM - StreetInsider Immunogen (IMGN) Reports Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab March 26, 2018 6:12 AM - StreetInsider Immunogen Inc. (IMGN) PT Raised to $20 at Canaccord Genuity March 26, 2018 2:10 AM - StreetInsider Immunogen Inc. (IMGN) PT Raised to $15 at Jefferies; 'Initial Mirve-Keytruda Data Shows Robust Activity' March 26, 2018 1:02 AM - StreetInsider ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Society of Gynecologic Oncology Annual Meeting March 24, 2018 6:00 PM - BizWire Form 4 IMMUNOGEN INC For: Mar 16 Filed by: JUNIUS DANIEL M March 16, 2018 5:13 PM - SEC Filing Form 4 IMMUNOGEN INC For: Mar 15 Filed by: Johnston David Brannon March 16, 2018 9:22 AM - SEC Filing ImmunoGen Announces Presentations at AACR Annual Meeting Highlighting Continued Innovation in ADCs March 14, 2018 4:31 PM - BizWire Form S-3ASR IMMUNOGEN INC March 7, 2018 5:36 PM - SEC Filing Form 10-K IMMUNOGEN INC For: Dec 31 March 7, 2018 4:48 PM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: Enyedy Mark J February 23, 2018 11:47 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: Ryll Thomas February 23, 2018 11:47 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: Wingrove Theresa February 23, 2018 11:47 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: Johnston David Brannon February 23, 2018 11:46 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: Berkenblit Anna February 23, 2018 11:46 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: BARROWS CRAIG February 23, 2018 11:46 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: Gregory Richard J. February 23, 2018 11:45 AM - SEC Filing Form 4 IMMUNOGEN INC For: Feb 21 Filed by: JUNIUS DANIEL M February 23, 2018 10:30 AM - SEC Filing Full Article List